{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:27:09Z","timestamp":1789936029079,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Bayer","award":["16\/fucap"],"award-info":[{"award-number":["16\/fucap"]}]},{"name":"Bayer","award":["GV29216"],"award-info":[{"award-number":["GV29216"]}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"publisher","award":["IIS53729 and IIS53792"],"award-info":[{"award-number":["IIS53729 and IIS53792"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cmi.2017.03.018","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T03:19:37Z","timestamp":1490411977000},"page":"640-646","source":"Crossref","is-referenced-by-count":73,"title":["Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients"],"prefix":"10.1016","volume":"23","author":[{"given":"J.","family":"Rello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Rouby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sole-Lleonart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Luyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Riera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Monsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dhanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.03.018_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/ALN.0000000000001570","article-title":"Nebulization of anti-infective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis","volume":"126","author":"Sol\u00e9-Lleonart","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.03.018_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1183\/09031936.01.00220001","article-title":"European Respiratory Society Guidelines on the use of nebulizers","volume":"18","author":"Boe","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2017.03.018_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/eri.13.36","article-title":"Delivering antibiotics to the lungs of patients with ventilator-associated pneumonia: an update","volume":"11","author":"Luyt","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2017.03.018_bib4","first-page":"1","article-title":"Nebulizers for drug delivery to the lungs","volume":"23","author":"Martin","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.cmi.2017.03.018_bib5","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e3182755d7a","article-title":"Nebulized Antibiotics Study Group. Aerosolized antibiotics for ventilator-associated pneumonia","volume":"117","author":"Rouby","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.03.018_bib6","first-page":"837","article-title":"Evaluation of aerosol generator devices at 3 locations in humidified and non-humidified circuits during adult mechanical ventilation","volume":"55","author":"Ari","year":"2010","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib7","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4187\/respcare.02637","article-title":"Ventilator-integrated jet nebulization systems: tidal volume control and efficiency of synchronization","volume":"59","author":"Ehrmann","year":"2014","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0928-0987(03)00148-9","article-title":"Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers","volume":"19","author":"Steckel","year":"2003","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.cmi.2017.03.018_bib9","first-page":"866","article-title":"The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia","volume":"52","author":"Dhand","year":"2007","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib10","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00134-008-1126-4","article-title":"Comparison of lung tissue concentrations of nebulized ceftazidime in ventilated piglets: ultrasonic versus vibrating plate nebulizers","volume":"34","author":"Ferrari","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00134-011-2420-0","article-title":"BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia","volume":"38","author":"Niederman","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib12","doi-asserted-by":"crossref","first-page":"R200","DOI":"10.1186\/cc8206","article-title":"Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia","volume":"13","author":"Luyt","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/jamp.2010.0860","article-title":"Pharmacokinetics and tolerability of amikacin administered as BAY41-6551 aerosol in mechanically ventilated patients with Gram-negative pneumonia and acute renal failure","volume":"24","author":"Luyt","year":"2011","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.cmi.2017.03.018_bib14","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4187\/respcare.03513","article-title":"Device cleaning and infection control in aerosol therapy","volume":"60","author":"O'Malley","year":"2015","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jamp.2007.0630","article-title":"Inhaled bronchodilator administration during mechanical ventilation: how to optimize it, and for which clinical benefit?","volume":"21","author":"Guerin","year":"2008","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.cmi.2017.03.018_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/QCO.0000000000000004","article-title":"Aerosolized antibiotics: do they add to the treatment of pneumonia?","volume":"26","author":"Kollef","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cmi.2017.03.018_bib17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1378\/chest.97.6.1327","article-title":"Droplets produced by medical nebulizers: some factors affecting their size and solute concentration","volume":"97","author":"Phipps","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2017.03.018_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/jamp.2009.0805","article-title":"Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating-mesh nebulizer","volume":"23","author":"Rao","year":"2010","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.cmi.2017.03.018_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-016-1448-5","article-title":"Fundamentals of aerosol therapy in critical care","volume":"20","author":"Dhanani","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1164\/rccm.201011-1894OC","article-title":"Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa","volume":"184","author":"Lu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/S0140-6736(10)60926-9","article-title":"Aerosol drug delivery: developments in device design and clinical use","volume":"377","author":"Dolovich","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2017.03.018_bib22","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.addr.2014.08.013","article-title":"Inhaled antimicrobial therapy\u2014barriers to effective treatment","volume":"85","author":"Weers","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cmi.2017.03.018_bib23","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00134-012-2628-7","article-title":"Pharmacokinetics of inhaled colistimethate sodium (CMS) in mechanically ventilated critically ill patients","volume":"38","author":"Athanassa","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib24","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1128\/AAC.03510-14","article-title":"Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients","volume":"58","author":"Boisson","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.03.018_bib25","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00134-010-1879-4","article-title":"Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa","volume":"36","author":"Lu","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib26","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.cmi.2017.03.018_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40560-015-0072-9","article-title":"Colistin for lung infection: an update","volume":"3","author":"Gurjar","year":"2015","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13054-015-0966-x","article-title":"Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!","volume":"19","author":"Honore","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/ajrccm.165.2.2107025","article-title":"Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs","volume":"165","author":"Goldstein","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1164\/rccm.200204-363OC","article-title":"Lung deposition and efficiency of nebulized amikacin during E.\u00a0coli pneumonia in ventilated piglets","volume":"166","author":"Goldstein","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib31","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000542-200304000-00033","article-title":"Lack of lung tissue and systemic accumulation after consecutive daily aerosols of amikacin in ventilated piglets with healthy lungs","volume":"98","author":"Ferrari","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.03.018_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00134-007-0935-1","article-title":"Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects","volume":"34","author":"Ehrmann","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib33","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1128\/AAC.02780-13","article-title":"Potentiation effects of amikacin and fosfomycin against selected amikacin\u2013non susceptible Gram-negative respiratory tract pathogens","volume":"58","author":"Montgomery","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.03.018_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1089\/jamp.2013.1100","article-title":"A\u00a0randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow\u00ae inline nebulizer system in mechanically ventilated patients","volume":"27","author":"Montgomery","year":"2014","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"10.1016\/j.cmi.2017.03.018_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01763-16","article-title":"Pharmacodynamics of aerosolized fosfomycin and amikacin against resistant clinical isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a hollow-fiber infection model: experimental basis for combination therapy","volume":"61","author":"Sime","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.03.018_bib36","unstructured":"Kollef MH, Ricard JD, Roux D, Francois B, Ischaki E, Rozgonyi Z, et\u00a0al. A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-negative ventilator-associated pneumonia: IASIS trial. Chest. In press."},{"key":"10.1016\/j.cmi.2017.03.018_bib37","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4187\/respcare.04519","article-title":"Intratracheal administration of antimicrobial agents in mechanically ventilated adults: an international survey on delivery practices and safety","volume":"61","author":"Sol\u00e9-Lleonart","year":"2016","journal-title":"Respir Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib38","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1128\/AAC.00490-09","article-title":"Serum concentrations of aerosolized tobramycin in medical, surgical, and trauma patients","volume":"53","author":"Burdette","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.03.018_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmi.2015.12.016","article-title":"Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines","volume":"22","author":"Sol\u00e9-Lleonart","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.03.018_bib40","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMc071717","article-title":"Compounded colistimethate as possible cause of fatal acute respiratory distress syndrome","volume":"357","author":"McCoy","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cmi.2017.03.018_bib41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmi.2017.04.011","article-title":"Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases","volume":"23","author":"Sol\u00e9-Lleonart","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2017.03.018_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199802053380602","article-title":"Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome","volume":"338","author":"Amato","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib43","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/cc8230","article-title":"Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial","volume":"14","author":"Determann","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-0034-1382155","article-title":"Ventilatory strategies in obstructive lung disease","volume":"35","author":"Parrilla","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/ALN.0b013e31826be693","article-title":"Acquired neuromuscular weakness and early mobilization in the intensive care unit","volume":"118","author":"Lipshutz","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cmi.2017.03.018_bib46","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s00134-013-3034-5","article-title":"Effect of sedation level on the prevalence of delirium when assessed with CAM-ICU and ICDSC","volume":"39","author":"Haenggi","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/bja\/aeu425","article-title":"Playing with fire: debate about propofol-induced hypotension","volume":"114","author":"Kakazu","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.cmi.2017.03.018_bib48","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1186\/cc5032","article-title":"Administration of antibiotics via the respiratory tract for the prevention of ICU-acquired pneumonia: a meta-analysis of comparative trials","volume":"10","author":"Falagas","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MCC.0b013e328330abcf","article-title":"Aerosolized antibiotics in critically ill ventilated patients","volume":"15","author":"Palmer","year":"2009","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.cmi.2017.03.018_bib50","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijid.2016.04.019","article-title":"Management of infections in critically ill returning travellers in the intensive care unit\u2014I: considerations on infection control and transmission of resistance","volume":"48","author":"Lebeblicioglu","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2017.03.018_bib51","first-page":"211","article-title":"Alteration in osmolarity of inhaled aerosols cause bronchoconstriction and cough, but absence of a permeant anion causes cough alone","volume":"129","author":"Eschenbacher","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.cmi.2017.03.018_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00134-012-2778-7","article-title":"The importance of protecting the mechanical ventilator during colistin methanesulfonate nebulization","volume":"39","author":"Mojoli","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2017.03.018_bib53","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ijid.2010.08.001","article-title":"Hypersensitivity pneumonitis due to high-dose colistin aerosol therapy","volume":"14","author":"Leong","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.cmi.2017.03.018_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s40265-014-0181-0","article-title":"Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis","volume":"74","author":"Conole","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.cmi.2017.03.018_bib55","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non\u2013cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17301878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X17301878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:53:39Z","timestamp":1719125619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X17301878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1198743X17301878"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.03.018","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}